Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Bastard

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Plos Medicine|May 1, 2019
Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational studyHelena Huerga, Sekai Chenai Mathabire Rucker, Loide Cossa, et al.
American Journal of Respiratory and Critical Care Medicine|January 31, 2015
Revised definitions of multidrug-resistant tuberculosis treatment outcomes: closer to the reality?Mathieu Bastard, Maryline Bonnet, Philipp du Cros, et al.
American Journal of Respiratory and Critical Care Medicine|July 2, 2015
Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?Mathieu Bastard, Maryline Bonnet, Philipp du Cros, et al.
PLOS Global Public Health|August 24, 2023
Factors associated with adverse outcomes among patients hospitalized at a COVID-19 treatment center in Herat, AfghanistanAna Klein, Mathieu Bastard, Hamayoun Hemat, et al.
BMC Infectious Diseases|August 21, 2019
The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimensUzma Khan, Helena Huerga, Aamir J Khan, et al.
Plos One|November 10, 2022
Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversionCarly A Rodriguez, Sara Lodi, C Robert Horsburgh, et al.
Emerging Infectious Diseases|April 20, 2019
Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant TuberculosisLawrence Mbuagbaw, Lorenzo Guglielmetti, Catherine Hewison, et al.
Plos One|March 9, 2018
Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort studyMathieu Bastard, Elisabeth Sanchez-Padilla, Philipp du Cros, et al.
Malaria Journal|February 7, 2023
Effect of large-scale mass drug administration for malaria on mortality and morbidity in Angumu health zone, Ituri, Democratic Republic of CongoLise Grout, Yves Katuala Givo, Trish Newport, et al.
PLOS Global Public Health|April 23, 2025
COVID-19, tuberculosis, and HIV triad: a prospective observational study in ambulatory patients in Kenya, Uganda, and South AfricaHelena Huerga, Maelenn Gouillou, Liesbet Ohler, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Plos Medicine|May 1, 2019
Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational studyHelena Huerga, Sekai Chenai Mathabire Rucker, Loide Cossa, et al.
American Journal of Respiratory and Critical Care Medicine|January 31, 2015
Revised definitions of multidrug-resistant tuberculosis treatment outcomes: closer to the reality?Mathieu Bastard, Maryline Bonnet, Philipp du Cros, et al.
American Journal of Respiratory and Critical Care Medicine|July 2, 2015
Reply: How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?Mathieu Bastard, Maryline Bonnet, Philipp du Cros, et al.
PLOS Global Public Health|August 24, 2023
Factors associated with adverse outcomes among patients hospitalized at a COVID-19 treatment center in Herat, AfghanistanAna Klein, Mathieu Bastard, Hamayoun Hemat, et al.
BMC Infectious Diseases|August 21, 2019
The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimensUzma Khan, Helena Huerga, Aamir J Khan, et al.
Plos One|November 10, 2022
Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversionCarly A Rodriguez, Sara Lodi, C Robert Horsburgh, et al.
Emerging Infectious Diseases|April 20, 2019
Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant TuberculosisLawrence Mbuagbaw, Lorenzo Guglielmetti, Catherine Hewison, et al.
Plos One|March 9, 2018
Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort studyMathieu Bastard, Elisabeth Sanchez-Padilla, Philipp du Cros, et al.
Malaria Journal|February 7, 2023
Effect of large-scale mass drug administration for malaria on mortality and morbidity in Angumu health zone, Ituri, Democratic Republic of CongoLise Grout, Yves Katuala Givo, Trish Newport, et al.
PLOS Global Public Health|April 23, 2025
COVID-19, tuberculosis, and HIV triad: a prospective observational study in ambulatory patients in Kenya, Uganda, and South AfricaHelena Huerga, Maelenn Gouillou, Liesbet Ohler, et al.
Pageof 7